What Are Monoclonal Antibodies and How Can They Fight Covid-19? | WSJ

65 432
3.2%
Published on 30 Sep 2021, 16:03
Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ

More from the Wall Street Journal:
Visit WSJ.com: wsj.com
Visit the WSJ Video Center: wsj.com/video

On Facebook: facebook.com/pg/wsj/videos
On Twitter: twitter.com/WSJ
On Snapchat: on.wsj.com/2ratjSM

#WSJ #monoclonalantibodies #antibodytreatment
newsautotechmusickids